Gallman Cari

US insider· US
Sign in for alerts
  • REDUCEDT+30

    Bristol-Myers Squibb Co · NASDAQ

    −2,332 sh · $142.6K

    Filed 5 Oct 2026SEC Form 4view source
  • ACQUIREDT+30

    Bristol-Myers Squibb Co · NASDAQ

    +4,559 sh

    Filed 5 Oct 2026SEC Form 4view source